ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Published online before print May 17, 2006
Eur Respir J 2006, doi:10.1183/09031936.06.00055805
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
28/2/311    most recent
09031936.06.00055805v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Watson, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Watson, L.


ORIGINAL ARTICLE

Predictors of COPD symptoms - does gender matter?

L. Watson 1, J.P. Schouten 1, C-G. Löfdahl 2, N.B. Pride 3, L.A. Laitinen 4, D.S. Postma 5*, on behalf of the European Respiratory Society Study on Chronic Obstructive Pulmonary Disease

1 Dept of Epidemiology and Bioinformatics, University Medical Centre Groningen, University of Groningen, Netherlands
2 Dept of Respiratory Medicine and Allergology, University Hospital, Lund, Sweden
3 Respiratory Division, Hammersmith Campus, NHLI, Imperial College, London, UK
4 Dept of Medicine, University Central Hospital, Helsinki, Finland
5 Dept of Pulmonology, University Medical Centre Groningen, University of Groningen, Netherlands

* To whom correspondence should be addressed. E-mail: d.s.postma{at}int.umcg.nl.


   Abstract

Though COPD patients frequently report symptoms, it is not known which factors determine the course of symptoms over time and if these differ by gender. This study investigated predictors for presence, development and remission of COPD symptoms in 816 men and 312 women completing three years follow-up in the Euroscop Study.

Explanatory variables of treatment, pack-years smoking, age, FEV1 % predicted, annual increase in FEV1 and number of cigarettes smoked, body mass index and phadiatop were included in GEE logistic regression analyses. Interaction terms of gender*explanatory variables were tested.

Over three years, similar proportions of men and women reported symptoms. In men only, higher FEV1 % predicted was associated with reduction in new symptoms of wheeze and dyspnoea and symptom prevalence reduced with annual FEV1 improvement and phlegm prevalence reduced with budesonide treatment (OR 0.66 95%CI 0.52-0.83). Additionally an increase in the number of cigarettes smoked between visits increased the risk of developing phlegm 1.40(1.14-1.70) and wheeze 1.24(1.03-1.51) in men but not women.

This study shows that longitudinally symptom reporting is similar by gender. The clinical course of COPD can differ by gender as men show greater response to cigarette exposure and treatment.

Keywords:  COPD, gender, lung function, symptoms, treatment




This article has been cited by other articles:


Home page
Proc Am Thorac SocHome page
P. G. Camp and S. M. Goring
Gender and the Diagnosis, Management, and Surveillance of Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, December 1, 2007; 4(8): 686 - 691.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
M. T. Dransfield, G. R. Washko, M. G. Foreman, R. S. J. Estepar, J. Reilly, and W. C. Bailey
Gender Differences in the Severity of CT Emphysema in COPD
Chest, August 1, 2007; 132(2): 464 - 470.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
A. von Leupoldt, S. Balewski, S. Petersen, K. Taube, S. Schubert-Heukeshoven, H. Magnussen, and B. Dahme
Verbal Descriptors of Dyspnea in Patients With COPD at Different Intensity Levels of Dyspnea
Chest, July 1, 2007; 132(1): 141 - 147.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2006 by the European Respiratory Society.